OTC : AAPGV

Ascentage Pharma Group International

$17.38 USD

$0.13 (0.75%)

Volume
2.22M
Average Volume
497.68K
Market Capitalization
$127.31M
P/E Ratio
-9.16
Dividend Yield
0.00%
Price Target
Year High
$18.00
Year Low
$16.50
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.79
Company Overview

OTC

Dajun Yang

Biotechnology

Healthcare

AAPGV

574

CN

USD

https://www.ascentage.cn

86 512 8555 7777

04390B105

0002023311

Liquidity Metrics

1.49

1.79

1.77

1.50

0.00

Sales & Valuation

$980.65M

20.76

8.86

-9.51

-13.39

Profitability

-$1.34

-$405.43M

-216.74%

-215.56%

-123.61%

-31.03%

P/E Metrics

-9.16

0.05

0.05

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Poll Results

About Ascentage Pharma Group International (OTC:AAPGV) Stock

Ascentage Pharma Group International is a clinical-stage biotechnology company focused on developing therapeutic solutions for various cancers, chronic hepatitis B virus (HBV) infection, and age-related conditions, primarily within Mainland China. Its flagship product candidate, HQP1351, is a BCR-ABL inhibitor specifically designed to target BCR-ABL1 mutants, notably those harboring the T315I mutation. The company's extensive pipeline further comprises: APG-2575, an orally administered, selective Bcl-2 inhibitor for hematologic malignancies and solid tumors. APG-115, an oral small-molecule inhibitor of MDM2-p53 protein-protein interactions, aimed at treating solid tumors and hematological cancers. APG-1252, a small-molecule drug engineered to restore apoptosis through dual inhibition of Bc ... l-2 and Bcl-xL proteins, indicated for small-cell lung cancer, non-small cell lung cancer, neuroendocrine tumors, and non-Hodgkin's lymphoma. APG-1387, a small-molecule inhibitor of apoptosis proteins for advanced solid tumors and chronic HBV infection. APG-2449, an oral inhibitor targeting FAK, ROS1, and ALK kinases. APG-5918, an orally available and selective embryonic ectoderm development inhibitor. APG-265, an MDM2 protein degrader. UBX1967/1325, which are also Bcl-2 inhibitors. Beyond its pharmaceutical development, Ascentage Pharma's operations encompass medical research and development, clinical trial management and execution, venture capital investments, rental services, and the promotion of science and technology. The company cultivates collaborative partnerships with various biotechnology and pharmaceutical enterprises, as well as academic research institutions. Established in 2009, Ascentage Pharma Group International is headquartered in Suzhou, China.

Frequently Asked Questions

What is the current Ascentage Pharma Group International (AAPGV) stock price?

Ascentage Pharma Group International(OTC:AAPGV) stock price is $17.38 in the last trading session. During the trading session, AAPGV stock reached the peak price of $18.0 while $16.5 was the lowest point it dropped to. The percentage change in AAPGV stock occurred in the recent session was 0.75% while the dollar amount for the price change in AAPGV stock was $0.13.

AAPGV's industry and sector of operation?

The OTC listed AAPGV is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of AAPGV?

Chongdong Fu | Senior Vice President & Head of CMC
Yifan Zhai | Chief Medical Officer
Cheung Ki Wong | Company Secretary
Raymond Jeffrey Kmetz | Chief Business Officer
Ming Guo | Co-Founder

How many employees does AAPGV have?

Number of AAPGV employees currently stands at 574. AAPGV operates from Suzhou Industrial Park, Suzhou, None 215000, CN.

Link for AAPGV official website?

Official Website of AAPGV is: https://www.ascentage.cn

How do I contact AAPGV?

AAPGV could be contacted at phone #86 512 8555 7777 and can also be accessed through its website. AAPGV operates from Suzhou Industrial Park, Suzhou, None 215000, CN.

How many shares of AAPGV are traded daily?

The average number of AAPGV shares traded daily for last 3 months was 497.68K.

What is the market cap of AAPGV currently?

The market value of AAPGV currently stands at $127.31M with its latest stock price at $17.38